Work

A new paradigm in CLL: Minimizing toxicity by using the minimum effective dose (MED) of lenalidomide for older patients with CLL.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.6609

Authors: Nicole Lamanna, Mark L. Heaney, Peter George Maslak, Joseph G. Jurcic, Todd L. Rosenblat, Ariela Noy, Maria Lia Palomba, Mark Adam Weiss

Institutions: Memorial Sloan Kettering Cancer Center, Thomas Jefferson University Hospital

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600058547

Cites:

Cited by: 2

Related to: 10